N-(4-Hydroxyphenylpropanoyl) spermine trihydrochloride

Discontinued Product

Unfortunately N-(4-Hydroxyphenylpropanoyl) spermine trihydrochloride (Cat. No. 0291) has been withdrawn from sale for commercial reasons.
Cat.No. 0291 - N-(4-Hydroxyphenylpropanoyl) spermine trihydrochloride | C19H34N4O2.3HCl | CAS No. 130631-59-3
Description: Wasp toxin analog. As Cat. No. 0290, but less selective
Chemical Name: N-(N-(4-Hydroxyphenylpropanoyl)-3-aminopropyl)-(N'-3-aminopropyl)-1,4-butanediamine trihydrochloride

Biological Activity

Wasp toxin analog. More potent than PhTX-343 at locust NMJ.

Technical Data

M. Wt 459.89
Formula C19H34N4O2.3HCl
Storage Desiccate at -20°C
CAS Number 130631-59-3

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

All Tocris products are intended for laboratory research use only.

Preparing Stock Solutions

The following data is based on the product molecular weight 459.89. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 2.17 mL 10.87 mL 21.74 mL
5 mM 0.43 mL 2.17 mL 4.35 mL
10 mM 0.22 mL 1.09 mL 2.17 mL
50 mM 0.04 mL 0.22 mL 0.43 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.


Dilution Calculator

Calculate the dilution required to prepare a stock solution.

Product Datasheets

Safety Datasheet


References are publications that support the products' biological activity.

Bycroft et al (1990) Invertebrate pharmacological assay of novel, potent glutamate antagonists: acylated spermines. Eur.J.Pharmacol. 183 470 PMID:

Smith et al (1990) Mono-acylated spermines: antagonists of glutamate receptors. Eur.J.Pharmacol. 183 472 PMID:

View Related Products by Target

View Related Products by Product Action

View all NMDA Receptor Antagonists

Keywords: N-(4-Hydroxyphenylpropanoyl) spermine trihydrochloride, supplier, NMDA, Receptors, NMDA, Receptors, Tocris Bioscience

Citations for N-(4-Hydroxyphenylpropanoyl) spermine trihydrochloride

Citations are publications that use Tocris products.

Currently there are no citations for N-(4-Hydroxyphenylpropanoyl) spermine trihydrochloride.

Reviews for N-(4-Hydroxyphenylpropanoyl) spermine trihydrochloride

There are currently no reviews for this product. Be the first to review N-(4-Hydroxyphenylpropanoyl) spermine trihydrochloride and earn rewards!

Have you used N-(4-Hydroxyphenylpropanoyl) spermine trihydrochloride?

Submit a review and receive an Amazon gift card.

$10US/$10CAN/€7/£6 gift card for a review without an image

$25US/$25CAN/€18/£15 gift card for a review with an image

*Offer only valid in the USA / Canada, UK and Europe

Submit a Review

Literature in this Area


Neurodegeneration Product Guide

A collection of over 275 products for neurodegeneration research, the guide includes research tools for the study of:

  • Alzheimer's disease
  • Parkinson's disease
  • Huntington's disease

Pain Research Product Guide

A collection of over 250 products for pain research, the guide includes research tools for the study of:

  • Nociception
  • Ion Channels
  • G-Protein-Coupled Receptors
  • Intracellular Signaling

Alzheimer's Poster

Alzheimer's disease (AD) is a degenerative brain disease and the most common cause of dementia, affecting approximately 47 million people worldwide. Updated in 2015, this poster summarizes the structural and functional changes observed in the progression of this neurodegenerative disease, as well as classic AD drug targets.


Depression Poster

Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.

Huntington's Disease

Huntington's Disease Poster

Huntington's disease (HD) is a monogenic neurodegenerative disorder, which is characterized by the prevalent loss of GABAergic medium spiny neurons (MSN) in the striatum. This poster summarizes the MSN intracellular signaling pathways implicated in the pathology of HD, as well as highlighting the use of iPSCs for HD modeling.

Learning & Memory

Learning & Memory Poster

Recognition memory enables us to make judgements about whether or not we have encountered a particular stimulus before. This poster outlines the cellular mechanisms underlying recognition memory and its links to long-term depression, as well as the use of pharmacological intervention to assess the role of neurotransmitters in recognition memory.


Pain Poster

Peripheral sensitization is the reduction in the threshold of excitability of sensory neurons that results in an augmented response to a given external stimulus. This poster outlines the excitatory and inhibitory signaling pathways involved in modulation of peripheral sensitization. The role of ion channels, GPCRs, neurotrophins, and cytokines in sensory neurons are also described.


Parkinson's Poster

Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.


Schizophrenia Poster

Schizophrenia is a debilitating psychiatric disorder that affects 1% of the worldwide population. This poster describes the neurobiology of Schizophrenia, as well as highlighting the genetic and environmental factors that play a fundamental role in the etiology of the disease. The current and emerging drug targets are also discussed.